<- Go Home
Dermapharm Holding SE
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Market Cap
EUR 1.9B
Volume
27.4K
Cash and Equivalents
EUR 195.6M
EBITDA
EUR 309.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 773.4M
Profit Margin
65.41%
52 Week High
EUR 51.90
52 Week Low
EUR 31.70
Dividend
2.26%
Price / Book Value
3.59
Price / Earnings
14.07
Price / Tangible Book Value
-3.55
Enterprise Value
EUR 2.9B
Enterprise Value / EBITDA
9.06
Operating Income
EUR 249.0M
Return on Equity
25.57%
Return on Assets
7.11
Cash and Short Term Investments
EUR 195.6M
Debt
EUR 1.2B
Equity
EUR 533.0M
Revenue
EUR 1.2B
Unlevered FCF
EUR 183.0M
Sector
Pharmaceuticals
Category
N/A